FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:318-319 January 17, 2008 Number 3

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

(Inside Technology.) By Shobita Parthasarathy. 271 pp., illustrated. Cambridge, MA, MIT Press, 2007. $35. ISBN 978-0-262-16242-5.

Clinical testing for BRCA mutations became available in 1996 as a means for the identification of women with a high lifetime risk of breast and ovarian cancer. This innovation was widely viewed as a medical breakthrough. Shobita Parthasarathy's intriguing but ultimately unconvincing book compares the introduction of BRCA testing in the United States and in the United Kingdom. In considering two societies with different health care systems but with much else in common, she seeks to determine how national context shapes the understanding and practice of genetic medicine.

At the heart of Parthasarathy's comparison is the rise of Myriad Genetics, . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.